Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intercept Pharmaceuticals, Inc. - Common Stock (NQ:ICPT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intercept Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
This has been a "historically challenging" population to treat. 
Via Investor's Business Daily
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Why Is Intercept Pharmaceuticals (ICPT) Stock Down 20% Today?
Market traders watched Intercept's recent clinical trial with anticipation. Unfortunately, the results fell short and ICPT stock is tanking. 
Via InvestorPlace
Wall Street Mixed; Dow Drops Over 50 Points
U.S. stocks traded mixed this morning, with the Dow Jones dropping more than 50 points on Friday. 
Via Benzinga
Intercept Pharma Summarizes Key Actions in Strategic Financial Repositioning
 
Via Benzinga
Intercept Settles Ocaliva Litigation With Reddy's Lab
 
Via Benzinga
Intercept Pharmaceutical Stock Sees RS Rating Rise To 91
Intercept Pharmaceutical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Where Intercept Pharmaceuticals Stands With Analysts
Within the last quarter, Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings: 
Via Benzinga
Intercept Shares Jump After Reissuing Annual Guidance
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) completed the sale of its international business for $405 million in upfront consideration. 
Via Benzinga
Needham Cuts Price Target On This NASH-Focused Stock As Its Awaits Visibility On Regulatory Path
 
Via Benzinga
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
What Is Going on With Clovis Oncology (CLVS) Stock Today?
Clovis Oncology (CLVS) stock is getting a boost on Wednesday as investors react to news of it reaching a two-year clinical supply agreement. 
Via InvestorPlace
Why Freyr Battery (FREY) Stock Could Be the Best EV Bet
Freyr Battery (FREY) stock is a hot topic among traders on Wednesday after Morgan Stanley weighed in on the electric vehicle (EV) company. 
Via InvestorPlace
Why Is Intercept Pharmaceuticals (ICPT) Stock Up Today?
Intercept Pharmaceuticals (ICPT) stock is on the move Wednesday after giving investors an update on how it improved its financials. 
Via InvestorPlace
Intercept Pharmaceutical Stock Shows Market Leadership; Earns 92 RS Rating
On Tuesday, Intercept Pharmaceutical stock had its Relative Strength Rating upgraded to 92, up from 89 a day earlier. 
Via Investor's Business Daily
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
What 6 Analyst Ratings Have To Say About Intercept Pharmaceuticals
Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Raymond James Maintains Outperform Rating for Intercept Pharmaceuticals: Here's What You Need To Know
Raymond James has decided to maintain its Outperform rating of Intercept Pharmaceuticals (NASDAQ:ICPT) and raise its price target from $26.00 to $28.00. Shares of Intercept Pharmaceuticals are trading... 
Via Benzinga
Stocks That Made New Highs On Friday, Aug. 19
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs. 
Via Talk Markets
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday
  GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Intercept Pharmaceuticals: Q2 Earnings Insights
  Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
7 Biotech Stocks to Buy for Q3
These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential. 
Via InvestorPlace
Analyst Ratings for Intercept Pharmaceuticals
Over the past 3 months, 4 analysts have published their opinion on Intercept Pharmaceuticals (NASDAQ:ICPT) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Why Did Intercept Pharmaceuticals (ICPT) Stock Fall 10% Today?
A fresh press release from Intercept Pharmaceuticals reveals positive data from an important clinical trial. Yet, ICPT stock is dropping. 
Via InvestorPlace
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.